Ossur hf
CSE:OSSR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
26.4
34.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Ossur hf
Cash & Cash Equivalents
Ossur hf
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Ossur hf
CSE:OSSR
|
Cash & Cash Equivalents
$77.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
|
Embla Medical hf
CSE:EMBLA
|
Cash & Cash Equivalents
$81.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
Ossur hf
Glance View
Össur hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. The firm is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The firm is divided into three market segments: Bracing and Supports, which offers products for therapeutic and preventive purposes; Prosthetics, which offers products for amputees, which include sockets, sleeves, prosthetic knees and feet, as well as supporting components, and Compression Therapy, which offers treatment for venous ulcers and edema. The firm's main markets are North America, Europe and Asia. The company has subsidiaries in Iceland, the United States, Canada, Mexico, France, the Netherlands, the United Kingdom, Sweden, Norway, Spain, South Africa, China and Australia.
See Also
What is Ossur hf's Cash & Cash Equivalents?
Cash & Cash Equivalents
77.4m
USD
Based on the financial report for Mar 31, 2024, Ossur hf's Cash & Cash Equivalents amounts to 77.4m USD.
What is Ossur hf's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
10%
Over the last year, the Cash & Cash Equivalents growth was 4%. The average annual Cash & Cash Equivalents growth rates for Ossur hf have been -4% over the past three years , 19% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
